|
BML-277
- 英文名称:BML-277
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B10018
- cas:516480-79-8
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-12-08
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B10018 |
| 用途 | 科研检测 |
| 英文名称 | BML-277 |
| 包装规格 | 1MG |
| CAS编号 | 516480-79-8 |
| 别名 | BML-277 |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:98% by TLC [50% ethyl acetate in hexanes; Rf = 0.17] NMR conforms
分子式:C20H14ClN3O2
分子量:363.81
溶剂:DMSO (20 mg/ml); Ethanol (20 mg/ml)
性状:Off-white solid
存储:-20°C
Activity (short version):CHK2 inhibitor
Function / Pharmacology:Potent selective inhibitor of Chk2 (IC50 = 15 nM). BML-277 has been screened against a panel of 35 kinases, and shows less that 25% inhibition of any other kinase at 10 μM, demonstrating the selectivity1. Also displays radioprotective activity, preventing apoptosis in human T-cells that were subjected to ionizing radiation (EC50 = 3.0 – 7.6 μM).
分子式:C20H14ClN3O2
分子量:363.81
溶剂:DMSO (20 mg/ml); Ethanol (20 mg/ml)
性状:Off-white solid
存储:-20°C
Activity (short version):CHK2 inhibitor
Function / Pharmacology:Potent selective inhibitor of Chk2 (IC50 = 15 nM). BML-277 has been screened against a panel of 35 kinases, and shows less that 25% inhibition of any other kinase at 10 μM, demonstrating the selectivity1. Also displays radioprotective activity, preventing apoptosis in human T-cells that were subjected to ionizing radiation (EC50 = 3.0 – 7.6 μM).



